Overview Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Status: Completed Trial end date: 2013-04-01 Target enrollment: Participant gender: Summary The objectives of this study are to examine the therapeutic effects of two doses of avanafil after dosing in men with erectile dysfunction Phase: Phase 4 Details Lead Sponsor: VIVUS, Inc.